Dr. Karla Esbona, from the UW Carbone Cancer Center, talks about a new research study that looks at an FDA approved drug that may improve the prognosis for patients with dense breast tissue.
Office of Strategic Communication
Dr. Karla Esbona, from the UW Carbone Cancer Center, talks about a new research study that looks at an FDA approved drug that may improve the prognosis for patients with dense breast tissue.